baber/WOPTO huggingface dataset:
Patent CA-2908067-A1 (CA)
Inventor: PARENT LUC
IPC: B01D29/39
Filed: 2014-06-05
Abstract: An edge closure system is presented herein wherein a portion of the closure edge of the filter bags leading to the outlet pipe aperture are provided with mating snapping closures, allowing to sealingly close the length of the edge of the fabric leading to the outlet pipe aperture simply by engaging the male and female components of the snapping closures. Moreover, an outlet pipe closure system is also presented herein using a combination of a tongue mounted internally to one of the sides of the fabric forming the bag in a manner to be wrappable around at least a corresponding portion of the outlet pipe, and a fabric hood mounted externally and overlapping both sides of the bag at the outlet pipe aperture, which cooperates with the tongue to seal the interface between the outlet pipe and the bag when held in position.
Patent CA-2909284-A1 (CA)
Inventor: HOSHI KIYOSHI
IPC: H01M8/10
Filed: 2014-03-27
Abstract: A fuel cell system includes an auxiliary machine to be connected to a fuel cell, warm-up power control means for controlling generated power of the fuel cell by adjusting power supplied to the auxiliary machine during the warm-up of the fuel cell, and IV characteristic estimation means for temporarily reducing the power supplied to the auxiliary machine and estimating an IV  characteristic of the fuel cell on the basis of at least two pairs of current values and voltage values at that time during the warm-up of the fuel cell.
Patent CA-2910458-A1 (CA)
Title: A thermodynamic machine
Inventor: LYNN ROBERT GULLIVER
IPC: F01K25/00
Filed: 2014-04-29
Abstract: A thermodynamic machipne, comprising: a rotor, configured to rotate about a rotor axis, a working fluid circulation path and a coolant fluid path formed within the rotor, the coolant fluid path fluidically isolated from the working fluid circulation path, the working fluid circulation path spanning radially from the rotor axis to close to the periphery of the rotor; a working fluid circulation drive configured to drive the circulation of a working fluid about the working fluid circulation path; at least one working fluid cooler heat exchanger formed as part of the working fluid circulation path and the coolant fluid path, in use coolant fluid passing through the working fluid cooler heat exchanger to transfer heat from the working fluid to the coolant fluid, and; a working fluid heater in the working fluid circulation path configured to heat a working fluid circulating around the working fluid circulation path.
Patent CA-2912515-A1 (CA)
Inventor: KACHMAR WAYNE M
IPC: H01B7/17
Filed: 2014-05-14
Abstract: The present disclosure relates to a hybrid cable having a jacket with a central portion positioned between left and right portions. The central portion contains at least one optical fiber and the left and right portions contain electrical conductors. The left and right portions can be manually torn from the central portion.
Patent CA-2914189-A1 (CA)
Title: Conjugaison enzymatique de polypeptides
Inventor: BREGEON DELPHINE
IPC: A61K47/48
Filed: 2014-06-20
Abstract: La présente invention concerne des procédés de fonctionnalisation enzymatique d'immunoglobulines, en particulier avec des médicaments. La présente invention concerne également des réactifs de liaison, des anticorps fonctionnalisés, des compositions pharmaceutiques et une méthode de traitement de maladie et/ou d'états pathologiques.
Patent CA-2917142-A1 (CA)
Title: Fluid valve apparatus having enclosed seals
Inventor: KOESTER DAVID J
IPC: F16K25/00
Filed: 2014-07-29
Abstract: Fluid valve apparatus having enclosed seals are disclosed. An example fluid valve includes a movable flow control member positioned between an inlet and an outlet of a fluid flow passageway of the fluid valve. A retainer is removably coupled to the flow control member such that the retainer and the flow control member define a sealing cavity when the retainer is coupled to the flow control member. A seal is positioned within the sealing cavity to define a sealing surface of the flow control member. The seal has an inner core composed of a first material, where the core is substantially encased with a sheath composed of a second material different than the first material. The retainer clamps the seal to the flow control member.
Patent CA-2919521-A1 (CA)
Inventor: LARSEN JAN
IPC: C12P7/10
Filed: 2014-02-05
Abstract: A method of processing lignocellulosic biomass comprising: - Providing soft lignocellulosic biomass feedstock, - Pretreating the feedstock at pH within the range 3.5 to 9.0 in a single-stage pressurized hydrothermal pretreatment to log severity Ro 3.75 or lower so as to produce a pretreated biomass slurry in which the undissolved solids comprise at least 5.0% by weight xylan, and Hydrolysing the pretreated biomass with or without addition of supplemental water content using enzymatic hydrolysis for at least 24 hours catalysed by an enzyme mixture comprising endoglucanase, exoglucanase, beta-glucosidase, endoxylanase, and beta-xylosidase activities at activity levels in nkat/g glucan of endoglucanase of at least 1100, exoglucanase of at least 280, beta-glucosidase of at least 3000, endoxylanase of at least 1400, and beta-xylosidase of at least 75, so as to produce a hydrolysate in which the yield of C5 monomers is at least 55% of the original xylose and arabinose content of the feedstock prior to pretreatment.
Patent CA-2920642-A1 (CA)
Title: Dispositif de detection de rayonnement comportant une structure d'encapsulation a tenue mecanique amelioree
Inventor: DUMONT GEOFFROY
IPC: G01J5/20
Filed: 2016-02-10
Abstract: L'invention porte sur un dispositif de détection de rayonnement électromagnétique, comprenant : - un substrat (3), - au moins un détecteur thermique (2), disposée sur le substrat, - une structure d'encapsulation (5) du détecteur, comportant une couche mince d'encapsulation (6) en un matériau transparent audit rayonnement, s'étendant autour et au-dessus du détecteur de manière à définir avec le substrat une cavité (4) dans laquelle le détecteur est situé, caractérisé en ce que la couche mince d'encapsulation comprend une paroi périphérique (6a) qui entoure le détecteur, et qui présente une section, dans un plan parallèle au plan du substrat, de forme carrée ou rectangulaire, dont les coins (6a-3) sont arrondis.
Patent CA-2923121-A1 (CA)
Inventor: LUCE WILLIAM E
IPC: F16B7/00
Filed: 2016-03-07
Abstract: The present disclosure describes lug clusters for composite tubes and methods for making such lug clusters. Lug clusters of the present disclosure may include a first side, a second side, and a saddle. The saddle may be placed in adjacent contact with a tube and a filament may be wound around the lug cluster and tube. The wound lug cluster and tube may be resin transfer molded. Machining may follow to remove material and finalize the shape of the lug cluster and/or tube. Thus, a lug cluster may be attached to a composite tube.
Patent CA-2923354-A1 (CA)
Title: Combination of epigenetic factors and bispecific compounds targeting cd33 and cd3 in the treatment of myeloid leukemia
Inventor: WALTER ROLAND B
IPC: A61P35/02
Filed: 2014-09-15
Abstract: The present invention provides a combination epigenetic factors and bispecific compounds targeting CD33 and CD3 in the treatment of myeloid leukemia, wherein the epigenetic factor is selected from the group consisting of histone deacetylase (HDAC) inhibitors, DNA methyltransferase (DNMT) I inhibitors,hydroxyurea, Granulocyte-Colony Stimulating Factor (G-CSF), histone demethylase inhibitors and ATRA (All Trans-retinoic acid). Accordingly, the invention provides a pharmaceutical composition comprising a CD33 targeting compound and at least one epigenetic factor and an epigenetic factor for use in the amelioration and/or treatment of a myeloid leukemia, wherein the epigenetic factor increases the responsiveness of a patient to a CD33 targeting compound. Moreover, the invention provides the use of at least one an epigenetic factor for increasing the responsiveness of a myeloid leukemia patient to a treatment with a CD33 targeting compound, a method for the treatment of a myeloid leukemia, the method comprising the administration of at least one epigenetic factor and a CD33 targeting compound to a patient in the need thereof and a kit comprising a pharmaceutical composition of the invention or an epigenetic factor of the invention and a bispecific CD33 targeting compound.
Patent CA-2923808-A1 (CA)
Title: Systeme de commande d'engin de chantier
Inventor: YAMASAKI RYOTA
IPC: B60L50/15
Filed: 2014-11-13
Abstract: Cette invention concerne un système de commande de camion-benne apte à traiter des sections de bloc en fonction d'une position de parcours et apte à réduire la masse d'informations transmises. Plus précisément, le système selon l'invention concerne un camion-benne (1), comprenant : une unité de demande de permission (4d) qui demande, quand un corps de véhicule (1a) parcourt une section de bloc prédéterminée (S1) sur un trajet à parcourir, la transmission d'un signal de demande de permission de déplacement à partir d'un dispositif embarqué sans fil (2b) afin de demander un signal de permission de déplacement qui permet le déplacement dans une section de bloc (S2) disposée devant la section de bloc (S1) ; et une unité de calcul (4c). Si, sur la base de la position de parcours détectée par un dispositif GPS (2a) il est déterminé qu'un déplacement est effectué dans la section de bloc (S1), l'unité de calcul (4c) modifie la fréquence de demande du signal de permission de déplacement par l'unité de demande de permission (4d) en fonction de la distance restant (a) jusqu'à un emplacement d'arrêt d'urgence (E1) disposé dans la section de bloc (S1) et devant le corps de véhicule (1a). L'invention comprend en outre un centre de commande (11) qui commande le déplacement du camion benne (1).
Patent CA-2926625-A1 (CA)
Inventor: CHEN ROGER J A
IPC: G01N27/406
Filed: 2014-09-11
Abstract: A method of identifying a molecule is disclosed. A molecule is drawn to a nanopore by applying a first voltage signal to a pair of electrodes during a first period, wherein the first voltage signal causes a first ionic current through the nanopore that is indicative of a property of a portion of the molecule proximate to the nanopore. The molecule is released from the nanopore by applying a second voltage signal to the pair of electrodes during a second period, wherein the second voltage signal causes a second ionic current through the nanopore. The first period and the second period are determined based at least in part on a net ionic current through the nanopore comprising the first ionic current and the second ionic current.
Patent CA-2927525-A1 (CA)
Title: Human antibody against aggrecanase-type adamts species for therapeutics of aggrecanase-related diseases
Inventor: MIYAKOSHI AKIRA
IPC: C07K16/40
Filed: 2014-10-14
Abstract: The present invention provides an antibody that specifically binds to human aggrecanase, and inhibits enzymatic activity of the human aggrecanase. In one embodiment, aggrecanase is ADAMTS4. In one embodiment, the antibody recognizes a particular epitope in human ADAMTS4, and inhibits not only aggrecanase activity of human ADAMTS4 but also aggrecanase activity of human ADAMTS5. In addition, the present invention also provides use of said antibody in the prophylaxis or treatment of the progression of arthritis.
Patent CA-2930722-A1 (CA)
Inventor: SHEN DANIEL Z
IPC: A61B5/00
Filed: 2014-11-17
Abstract: L'invention concerne des procédés, des systèmes et des dispositifs pour surveiller une orientation, direction, altitude et localisation d'un patient pour déterminer le besoin de rotation et pour détecter des sorties ou chutes de lit immanentes ou réelles. Un capteur porté par un patient communique avec au moins un serveur hôte au moyen d'un réseau maillé d'antennes relais pour fournir des données représentant diverses caractéristiques de patient. Le capteur comprend un accéléromètre, un magnétomètre et/ou un altimètre, conjointement avec d'autres capteurs facultatifs. Diverses interfaces utilisateurs sont conçues pour gérer des soins de patient à l'aide des informations développées par des algorithmes traités par le serveur sur la base des données reçues en provenance des capteurs de patient.
Patent CA-2933027-A1 (CA)
Title: Adhesive formulation and creping methods using same
Inventor: TAN JIAN
IPC: C09J11/00
Filed: 2014-12-05
Abstract: A formulation useful as a creping adhesive formulation or Yankee dryer coating composition is described. Methods of creping using the formulation are also described.
Patent CA-2935033-A1 (CA)
Title: Systems and methods for forming retread tires using flat backed tread
Inventor: WESTAWAY TERRY A
IPC: B29D30/54
Filed: 2014-12-16
Abstract: Retreaded tires and methods for manufacturing the same. A tire is retreaded with a pre-cured tread band having a smooth back face and one or more tread grooves with compliant skid base gauge on a front face. The grooves in the pre-cured tread band align with grooves in a tire casing and upon curing conform to the shape of the casing grooves. The tire tread depths are greater than the original tire tread depth of the pre-cured tread band, thereby increasing the wear volume of the tire tread.
Patent CA-2935302-A1 (CA)
Inventor: BONELLI SAURO
IPC: A61K31/573
Filed: 2014-12-23
Abstract: The invention concerns an aerosol solution composition intended for use with a pressurised metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or more additional active ingredient, stabilised by a selected amount of a mineral acid and wherein the amount of the degradation product N-(3 -bromo)- [2-hydroxy-5-[1-hydroxy-2-[1-(4- methoxyphenyl)propan-2-ylamino] ethyl] phenyl] formamide is lower than the limit of quantification, when stored in accelerated conditions at 25°C and 60% relative humidity (RH) for at least 3 months in an aerosol can provided with a metering valve having at least a butyl rubber gasket. The optional one or more active ingredient may be an inhalation corticosteroid selected from beclometasone dipropionate, budesonide or its 22R-epimer, ciclesonide, flunisolide, fluticasone propionate, fluticasone furoate, mometasone furoate, etc.
Patent CA-2935303-A1 (CA)
Inventor: YU YUE
IPC: H04N19/70
Filed: 2014-12-30
Abstract: A system for signaling extension functions used in decoding a sequence including a plurality of pictures, each picture processed at least in part according to a picture parameter set is disclosed. An extension presence signaling flag is read and used to determine whether flags signaling the performance of extension functions are to be read. The flags are only read if indicated by the extension presence signaling flag.
Patent CA-2938482-A1 (CA)
Title: Implantable medical device comprising heparin and paclitaxel layers
Inventor: ANTONI PER
IPC: A61L33/10
Filed: 2015-03-13
Abstract: According to the invention there is provided inter alia an implantable medical device with coatings comprising an immobilized heparin moiety and elutable paclitaxel and to methods for making such devices.
Patent CA-2939348-A1 (CA)
Inventor: COMEAU Jerry
IPC: A41B1/00
Filed: 2016-08-12
Abstract: A shirt or garment to be worn by a person and having a flip-up panel that is connected to a front panel of the shirt or garment, wherein the flip-up panel is movable between a lowered position in which it substantially covers the front panel to.a raised position in which a portion of the front panel previously covered by the front panel is exposed and the flip-up panel substantially covers a face of the person.
Patent CA-2940730-A1 (CA)
Title: Drap hybride ayant une maille perforee recouverte de gel
Inventor: LOCKE CHRISTOPHER BRIAN
IPC: A61M1/00
Filed: 2015-02-11
Abstract: L'invention concerne un système pour traiter un site de tissu à l'aide d'une pression négative. Le système comporte un collecteur conçu pour être situé adjacent au site de tissu, et un drap conçu pour être positionné sur le site de tissu et le collecteur pour former un espace étanche. Le système comprend également une source de pression négative configurée pour fournir une pression négative à l'espace étanche. Le drap comprend une couche de film, une couche d'un adhésif de fixation couplée à la couche de film, et une maille couplée à la couche de l'adhésif de liaison. La maille comprend un revêtement d'un adhésif d'étanchéité et une ou plusieurs ouvertures de liaison. L'invention concerne aussi des procédés permettant de fabriquer de tels draps.
Patent CA-2942552-A1 (CA)
Title: Sequential removal of ngls from a natural gas stream
Inventor: MATTEUCCI SCOTT T
IPC: C10L3/10
Filed: 2014-08-05
Abstract: Disclosed is a method of sequentially separating and recovering one or more NGLs (129, 229) from a natural gas feedstream (3). Specifically, a raw natural gas feedstream (3) is passed through two or more NGLs separation unit (100, 200) wherein each separation unit removes one or more NGLs from the natural gas feedstream to provide a methane-rich natural gas supply (205). Each separation unit employs an adsorption media and has an adsorption step and a media regeneration step wherein the regeneration step may be operated as a batch process, a semi-continuous process, or a continuous process. One embodiment of this method provides for the use of a different regenerable adsorbent media in each separation unit.
Patent CA-2943072-A1 (CA)
Inventor: COTE PIERRE LUCIEN
IPC: C02F11/123
Filed: 2015-03-11
Abstract: L'invention concerne le traitement d'eaux usées par l'intermédiaire du traitement primaire de l'eau au moyen d'un micro-tamis afin d'obtenir un effluent primaire et une boue primaire. L'invention est un traitement secondaire de l'effluent primaire au moyen d'un bioréacteur à membrane (MBR) ou d'un réacteur à boue activée et film fixe intégré (IFAS) afin de produire un effluent secondaire et une boue activée par déchets. Le micro-tamis peut présenter des ouvertures de 250 microns ou moins, par exemple environ 150 microns. Dans un procédé, une membrane de transfert de gaz est immergée dans de l'eau. De l'air sous pression s'écoule dans la membrane de transfert de gaz. Un gaz d'échappement est retiré de la membrane de transfert de gaz et utilisé pour produire des bulles à partir d'un aérateur immergé dans l'eau.
Patent CA-2943945-A1 (CA)
Inventor: HAQUE EHTESHAMUL
IPC: B65H18/10
Filed: 2010-10-26
Abstract: A sheet product comprises a length of a wound first sheet product material defining a tubular roll having an outer diameter; and a semi-rigid core portion comprising the first sheet product material defining an outer diameter of a void portion concentric to the outer diameter of the roll. The void portion has a plurality of layers of the wound first sheet product hardened non-uniformly across a cross section of the void portion such that there is a hardened first core portion and a hardened second core portion on opposed ends of the void portion, wherein the first core portion includes an indented portion concentric to the outer diameter of the roll, defining an outer diameter greater than the outer diameter of the void portion, and wherein the second core portion includes an indented portion concentric to the outer diameter of the roll, defining an outer diameter greater than the outer diameter of the void portion.
Patent CA-2945281-A1 (CA)
Inventor: OEHRING JARED
IPC: E21B23/08
Filed: 2016-10-14
Abstract: A method of operations in a subterranean formation, including driving a pump with an electrically powered motor to pressurize fluid, inserting a tool into a wellbore that intersects the formation, and directing the pressurized fluid into the wellbore above the tool to push the tool into the wellbore.
Patent CA-2946053-A1 (CA)
Title: Oral care compositions having improved stability
Inventor: LI YUJUN
IPC: A61K8/27
Filed: 2014-05-14
Abstract: An oral composition which can improve stability via the removal of stannous ions is provided. The composition includes low molecular weight polyethylene glycols (PEGs). A method for treating the oral cavity is also provided, comprising administering to the oral cavity an oral care composition according to the present invention.
Patent CA-2949478-A1 (CA)
Inventor: ESPESET TONNY
IPC: H04N19/44
Filed: 2014-09-30
Abstract: Systems and methods for encoding and playing back video at adjustable playback speeds by interpolating frames to achieve smooth playback in accordance with embodiments of the invention are described. One embodiment includes a source encoder that includes a processor, memory including an encoder application, where the encoder application directs the processor to: select a subset of frames from a first video sequence; generate motion vectors describing frames from the first video sequence that are not part of the selected subset of frames, where each motion vector describes movement between a frame in the subset of frames and a frame not included in the subset of frames; store the motion vectors; decimate frames not included in the subset of frames from the first video sequence to generate a second video sequence having a nominal frame rate less than the frame rate of the first video sequence; and encode the second video sequence at the nominal frame rate.
Patent CA-2950367-A1 (CA)
Inventor: TSUCHIMOTO NORIHIKO
IPC: A23L2/52
Filed: 2013-03-18
Abstract: The invention provides a method for producing a soy milk fermentation product, comprising an enzyme treatment step of hydrolyzing soy milk with a peptide bond hydrolase to obtain a fermentation substrate, and a fermentation step of fermenting the fermentation substrate with lactic acid bacteria belonging to Lactobacillus brevis to obtain a fermentation product.
Patent CA-2950763-A1 (CA)
Inventor: ADUSUMILLI PRASAD S
IPC: A61K39/00
Filed: 2015-06-05
Abstract: The presently disclosed subject matter provides for methods and compositions for enhancing the immune response toward cancers and pathogens. It relates to chimeric antigen receptors (CARs) that specifically target human mesothelin, and immunoresponsive cells comprising such CARs. The presently disclosed mesothelin-targeted CARs have enhanced immune-activating properties, including anti-tumor activity.
Patent CA-2953340-A1 (CA)
Title: Simulation system and method for integrating client behavioral preferences within decision-based simulation scenarios
Inventor: HANLON ROBERT PAUL
IPC: G06Q40/00
Filed: 2015-06-19
Abstract: Client decision-making behavioral preferences for evaluating or coping with unknown outcomes (risk temperament or "RT") and absorbing information (preference typology or "PT") during decision-making events are identified and classified by processing client responses to questions. Behavioral preferences are classified and stored in a behavior-influenced decision-making data set (BDDS). The simulator also receives an objective decision-making data set (ODDS) of factually objective inputs. The simulator combines and triangulates the PT and RT information contained in the BDSS with the ODDS and derives a new data set of resultant output goals (OGDS). The transformed OGDS output is displayed as a triangulation of the simulator's RT, PT, and ODDS, with a balanced OGDS displayed as a bubble or spirit level. Out of balance status identifies deviation from intended outcome. OGDS decision-making tools can be recursively combined as modular blocks to create decision-making tools for other desired outcomes.
Patent CA-2955053-A1 (CA)
Title: Novel 2,5-substituted pyrimidines as pde4 inhibitors
Inventor: NARDI ANTONIO
IPC: C07D401/14
Filed: 2015-07-16
Abstract: The invention relates to novel substituted condensed pyrimidine compounds of general formula (I) in which the chemical groupings, substituents and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.